The dual lipid desaturase/hydroxylase DEGS2 controls phytoceramide levels necessary to counter intestinal inflammation
Intestinal immunity is dependent on barrier function to maintain quiescence.  The mechanisms for the maintenance of this barrier are not fully understood.  Delta 4-desaturase, Sphingolipid 2 (DEGS2) is a lipid desaturase and hydroxylase, which catalyzes the synthesis of ceramide and phytoceramide from dihydroceramide. Using a forward genetic approach, we found and validated a mutation in Degs2 as causative in increasing susceptibility to colitis and altering the phytoceramide balance in the colon. DEGS2 is expressed in the intestinal epithelium, and the colitis phenotype is dependent on the non-hematopoietic compartment of the mouse. In the absence of DEGS2, the colon lacks phytoceramides and accumulates large amounts of the precursor lipid dihydroceramide. In response to DSS induced colitis, colonic epithelial cells in DEGS2-deficient mice had increased cell death and decreased proliferation compared to those in wildtype mice. These findings demonstrate that DEGS2 is needed to maintain epithelial integrity, protect against DSS-induced colitis and maintain lipid balances in vivo. Overall design: Transcriptome analysis of the colonic epithelial cells from control and Degs2 deficient mice